Parotid secretory protein (PSP) is an abundant protein in mouse and rat parotid glands. A related sequence (C20orf70) was identified on human chromosome 20. The goal of this study was to determine if PSP is expressed in the human parotid gland. The cDNA for human PSP was amplified from a human parotid cDNA sample. A peptide antibody, raised to the C-terminal peptide of PSP, identified the protein in human parotid tissue by immunofluorescence microscopy. Immunoaffinity chromatography suggested that PSP was expressed in human saliva. PSP is related to bactericidal/permeability-increasing protein (BPI). To test if PSP exhibits anti-bacterial activity, epitope-tagged PSP was expressed in rat GH4C1 cells. The secretion medium exhibited bacteristatic or bactericidal effects on Pseudomonas aeruginosa in a colony-forming assay when compared with secretion medium from GH4C1 cells that did not express PSP. These results suggest that PSP is expressed in the human parotid gland and saliva, where it functions as a BPI-like anti-bacterial protein.
Introduction
Parotid secretory protein (PSP) is a major salivary protein that is expressed in mouse [1] and rat [2] parotid glands. A related protein, BSP30 or bovine PSP, is expressed in bovine saliva [3] . PSP is also expressed in the mouse lacrimal gland [4] and in neonatal rat submandibular glands [2] . The goal of the present study was to determine if PSP is expressed in the human parotid gland.
On analysis of the human genome sequence, a gene (C20orf70) that is related to rodent and bovine PSP has recently been identified on chromosome 20q11 [5] . This region corresponds to mouse chromosome 2, the location of the mouse PSP gene. The C20orf70 gene product, SPLUNC2 [short PLUNC (palate, lung and nasal epithelium clone) 2] or PSP, is expressed in the submandibular glands [5] , and belongs to a family of oral and airway epithelial secretory proteins that includes PSP, BSP30, SMGB (submandibular gland protein B), von Ebner minor salivary gland protein and several species of PLUNC/LUNX (lung-specific X protein)/SPURT (secretory protein in upper respiratory tract) [5] [6] [7] [8] [9] [10] [11] .
Sequence-sequence comparison and sequence-structure analysis have revealed that PSP/PLUNC proteins are related to a family of mammalian lipid-binding proteins that includes bactericidal/permeability-increasing protein (BPI), lipopolysaccharide-binding protein (LBP), cholesteryl ester transport protein and phospholipid transport protein [5, 7, 9] . The sequence identity is low (22%), but this has also been observed for other proteins related to this family [12] . Two conserved Cys residues are found in BPI-like proteins, where they form a disulphide bridge. These Cys residues are also found in the PSP/PLUNC proteins.
The similarity between PSP and BPI/LBP is of particular interest, since it points to an anti-bacterial or anti-inflammatory function for PSP. BPI acts as an antiinflammatory protein by inhibiting the binding of endotoxin (lipopolysaccharide) to LBP. Thus it is likely that common structures in BPI and LBP interact with endotoxin [13] . The anti-inflammatory activity of BPI is located in the Nterminal domain, while the C-terminal domain appears to mediate binding to CD14 [14] . The N-and C-terminal domains are necessary for the bacterial opsonizing activity of BPI [13] . PSP is most closely related to the N-terminal domain of BPI, suggesting that PSP may exhibit both antibacterial and anti-inflammatory activities. Indeed, mouse PSP binds bacteria, and the protein has been associated with the chronic inflammatory disease Sjogren's syndrome. The nonobese diabetic (NOD) mouse model of Sjogren's syndrome exhibits lymphocytic infiltration of salivary glands and salivary dysfunction [15] . PSP is abundantly expressed in the parotid glands of normal mice [1] . The normal 20.5 kDa PSP protein is post-translationally processed by saliva from NOD mice to yield a 17 kDa product [16] . This processing coincides with the appearance of lymphocytic infiltrates in the salivary glands of NOD mice [17] . Identification and isolation of human PSP (hPSP) is a prerequisite for determining its potential role in human inflammatory diseases.
Results
BLAST analysis revealed that a sequence on human chromosome 20 is similar to rat PSP and the bovine salivary protein BSP30. Based on this open reading frame (C20orf70), the Tissue sections were examined for immunoreactivity with anti-hPSP antiserum at a dilution of 1:50 and visualized with FITC-conjugated sheep anti-rabbit IgG at a dilution of 1:5000, using a Nikon fluorescence microscope at a magnification of 40×. The blank was incubated with secondary antibody alone.
cDNA for hPSP was amplified from a human parotid cDNA sample (Invitrogen). Human amylase was amplified as a tissue control. The PCR products were analysed by agarose gel electrophoresis, which revealed single bands of the expected size for PSP (750 bp) and amylase (1.5 kb) (results not shown). The level of expression of the PSP mRNA appeared similar to that of amylase, consistent with observations in the mouse parotid gland [18] . The hPSP cDNA was cloned in the Topo cloning vector (Invitrogen) and sequenced. It is identical to the sequence of SPLUNC2, which is expressed in the human submandibular gland [5] .
To localize PSP in human parotid tissue, a peptide antibody was raised to the C-terminal peptide of PSP and used for immunofluorescence microscopy. Preliminary experiments were conducted with tissue from a single human parotid gland. Figure 1 shows that PSP was expressed in ductal epithelial cells and acinar cells. Amylase was limited to parotid acinar cells (results not shown). The pattern of expression of PSP in the human gland appeared to differ from that in the rat, where PSP was not found in intercalated ductal epithelia cells of the adult animal [19] .
To isolate PSP directly from human saliva, the IgG fraction of the PSP peptide antiserum was coupled to CNBrSepharose and used for immunoaffinity chromatography. Human saliva was collected from 25 healthy adult volunteers by citric acid stimulation after an overnight fast (University of Louisville IRB protocol HSC#468.01). The samples were centrifuged and the supernatant, free of mucin and cellular debris, was loaded on the affinity matrix. Unbound protein was removed by washing with 0.1 M potassium phosphate buffer, pH 7.0, and the bound fraction was eluted with 0.2 M glycine, pH 2.0. The purity of the eluate was analysed by SDS/PAGE (4-20% gradient gel; silver stain). A dominant protein band with an apparent molecular mass of between 36 and 49 kDa was identified (Figure 2, left panel) . This protein also reacted with the anti-PSP antibody upon immunoblotting (results not shown). Further attempts to characterize the eluted protein were consistent with it representing PSP, although neither Edman degradation nor amino acid analysis yielded conclusive results. N-terminal sequence data could not be obtained by Edman degradation of the purified human protein, as reported previously for the related protein PLUNC [20] . Presumably, both PSP and PLUNC contain blocked N-termini. Amino acid analysis of the purified protein revealed a high content of leucine (17%), consistent with that predicted from the PSP sequence. However, hydrolysis was incomplete, which is consistent with the high content of hydrophobic amino acids predicted for PSP. Epitope-tagged hPSP was expressed in Escherichia coli and the mammalian cell lines GH4C1 and PC12. The protein expressed in bacteria exhibited a molecular mass of 27 kDa (+3 kDa for the epitope tags), as predicted from the amino acid sequence (Figure 2, right panel) . The protein expressed in rat cell lines exhibited a molecular mass of 37 kDa (+3 kDa for the epitope tags) (Figure 2, right panel) . This size difference suggested that hPSP undergoes post-translational modifications in mammalian cells. The larger size of the salivary protein suggested that it might undergo more extensive post-translational modifications than the protein expressed in cultured cells. hPSP expressed in the mammalian cell lines GH4C1 and PC12 exhibited stimulated secretion, suggesting that it was sorted to the regulated secretory pathway. Indeed, we have recently found that rat PSP is sorted to the regulated secretory pathway in both GH4C1 and PC12 cells [21] .
Secretion medium from GH4C1 cells that expressed recombinant epitope-tagged hPSP exhibited bacteristatic or bactericidal effects on Pseudomonas aeruginosa in a colonyforming assay when compared with secretion medium from GH4C1 cells that did not express PSP (negative control) ( Figure 3) .
P. aeruginosa are Gram-negative bacteria that express endotoxins on the cell surface. To test if PSP could exhibit anti-endotoxin activity, as reported previously for BPI [22] , PSP peptides that corresponded to the anti-inflammatory domain of BPI were designed [23, 24] . The PSP-derived peptides inhibited the binding of endotoxin to LBP and inhibited the endotoxin-stimulated secretion of tumour necrosis factor α from macrophages (results not shown). Together, these data suggest that PSP acts as an anti-bacterial and anti-inflammatory protein in the oral cavity.
Discussion
PSP is an abundant protein in parotid secretory granules of rats and mice. A related protein is readily detected in bovine saliva. We now show that PSP is also expressed in the human salivary gland, where its level of expression appears to be similar to that of amylase, a major secretory protein in the parotid gland. PSP expression has also been detected in the human submandibular gland, where it was termed SPLUNC2 [5] . It is not known if the human gene exhibits developmental regulation similar to that reported for rat PSP [19] . A PSP-like protein was isolated by immunoaffinity chromatography of human saliva. While this protein has not yet been conclusively identified as PSP, all data are consistent with this interpretation. Further purification experiments are under way to obtain sufficient material for MS or Edman degradation of tryptic peptides.
PSP is similar to the endotoxin-binding proteins BPI and LBP. Using recombinant PSP and PSP peptides, our preliminary data suggest that PSP is also an anti-bacterial and anti-inflammatory protein. By extension, it is likely that similar functions will be found for other members of the PSP/PLUNC protein family. Together, these proteins may serve protective functions in the oral cavity, upper airways and lungs. It remains to be determined if the differential expression of PSP and PLUNC proteins reflects a functional diversity. Thus these proteins could respond to different pathogens, or their expression could be linked to the expression of cofactors or other host-defence proteins in the oral cavity and airways. Indeed, the expression of PLUNC appears to be regulated by environmental factors [20] . It remains to be determined if PSP expression is also regulated by environmental or endogenous factors.
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